Modi said India was moving ahead with Phase 3 clinical trials - the large-scale trials considered the gold standard for determining safety and efficacy - and would help all countries enhance their cold chain and storage capacities for the delivery of vaccines. He said in August that India was ready to mass produce Covid-19 vaccines when scientists gave the go-ahead.
